Author Correction: Inflammasome signalling in brain function and neurodegenerative disease.
Where this comes from
- Record sourced from PubMed, PMID 30742056.
- Also identified by DOI 10.1038/s41583-019-0137-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: 'M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.' This error has been corrected in the HTML and PDF versions of the article.